IUAB 1677: Optimizing Post-Allogeneic Hematopoietic Cell Transplant Outcomes for Lymphoma using Ibrutinib

Grant

Date/time Interval

  • March 20, 2017 - March 19, 2022
  • Awarded By

    Total Award Amount

  • 47684.00
  • Direct Costs

  • 36680.00
  • Sponsor Award Id

  • Contributor

  • Costa M.D., Ph.D., Luciano   Principal Investigator  
  • Di Stasi M.D., Antonio   Investigator  
  • Innis-Shelton M.D., Racquel   Investigator  
  • Salzman M.D., Donna   Investigator